Literature DB >> 7545472

Epstein-Barr virus modulates de novo protein synthesis in human neutrophils.

A D Beaulieu1, R Paquin, J Gosselin.   

Abstract

Neutrophils and macrophages represent the first line of defense against microbial invaders. However, the role of phagocytes in host response to viral infection is poorly understood. We have previously shown that Epstein-Barr virus (EBV) interacts with human monocytes and modulates cytokine production in this cell type, but its effects on neutrophils are still unknown. In the present study, we investigated the presence of EBV receptor (CR2 or CD21) on neutrophils by cytofluorometry using five different anti-CD21 monoclonal antibodies (MoAbs), as well as fluoroscein isothiocyanate-EBV (FITC-EBV). Whereas no significant amount of neutrophils reacted with anti-CD21 MoAbs, studies with FITC-EBV indicated that viral particles bind to 30% of cells (in some individuals, EBV binds to more than 50% of neutrophils). This interaction is specific as it was completely inhibited by nonconjugated virus or with labeled virus preincubated with neutralizing MoAbs. After EBV treatment, cellular aggregation was observed in neutrophil cultures, an indication that neutrophils were activated. Although EBV did not induce respiratory burst activity in neutrophils, pretreatment with infectious particles enhanced (priming effect) the fMLP-induced O2- release in neutrophils. Instead of restricting our analysis to specific cytokine genes, we investigated the effects of EBV on neutrophil transcriptional events in general. The effect of this virus on de novo synthesis of total cellular RNA was first investigated by measuring the incorporation of [5-3H] uridine into total RNA. The results showed that RNA synthesis in neutrophils was significantly increased (2.3- to 21.3-fold) by EBV compared with the unstimulated controls. Live and UV-inactivated virus markedly induced RNA synthesis, whereas heat-inactivated virus lost this ability. Induction of RNA transcription was EBV specific, as an EBV-neutralizing antiserum abolished this effect. Induction of protein synthesis was also studied by measuring the incorporation of [35S] methionine and [35S] cysteine into secreted and intracellular proteins in neutrophils incubated with EBV. The synthesis of both secreted and cytoplasmic proteins was induced by EBV. One- and two-dimensional gel electrophoresis analysis showed that EBV modulates protein synthesis, because activation of the synthesis of certain proteins was accompanied by the inhibition of others. Interleukin-1 beta (IL-1 beta) and IL-1 receptor antagonist (IL-1Ra) synthesis was found to be induced by EBV. Therefore, modulation of host-response proteins such as IL-1Ra could be one of the many mechanisms by which this virus avoids rejection.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545472

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Infection of primary human monocytes by Epstein-Barr virus.

Authors:  M Savard; C Bélanger; M Tardif; P Gourde; L Flamand; J Gosselin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Identification and cloning of the SNARE proteins VAMP-2 and syntaxin-4 from HL-60 cells and human neutrophils.

Authors:  J E Smolen; R J Hessler; W M Nauseef; M Goedken; Y Joe
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

3.  Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4.

Authors:  J Gosselin; M Savard; M Tardif; L Flamand; P Borgeat
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection.

Authors:  François Michaud; François Coulombe; Eric Gaudreault; Jasna Kriz; Jean Gosselin
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

5.  Human herpesvirus 6 latently infects early bone marrow progenitors in vivo.

Authors:  M Luppi; P Barozzi; C Morris; A Maiorana; R Garber; G Bonacorsi; A Donelli; R Marasca; A Tabilio; G Torelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2.

Authors:  Eric Gaudreault; Stéphanie Fiola; Martin Olivier; Jean Gosselin
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 7.  Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.

Authors:  Debora Martorelli; Elena Muraro; Anna Merlo; Riccardo Turrini; Damiana Antonia Faè; Antonio Rosato; Riccardo Dolcetti
Journal:  Clin Dev Immunol       Date:  2012-01-29

Review 8.  Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.

Authors:  Yong Shen; Suzhan Zhang; Ren Sun; Tingting Wu; Jing Qian
Journal:  Emerg Microbes Infect       Date:  2015-03-25       Impact factor: 7.163

Review 9.  Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.

Authors:  Alessandro Allegra; Vanessa Innao; Andrea Gaetano Allegra; Marta Pugliese; Eleonora Di Salvo; Elvira Ventura-Spagnolo; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2019-06-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.